Loading in 2 Seconds...
Loading in 2 Seconds...
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Global Neurodegenerative Diseases Market 2015-2019
According to the EU JPND, neurodegenerative diseases refer to conditions that involve the neurons in the brain. These conditions can affect balance, movement, speech, and respiratory and cardiac functions. They can be inherited or be of unknown etiology. Neurodegenerative diseases are incurable and are severely debilitating. They result in progressive degeneration of nerve cells, causing them to die eventually. These diseases cause ataxia and dementia in people, which can have a serious impact on the mental health of patients. Some examples of neurodegenerative diseases are Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, multiple sclerosis, amyotrophic lateral sclerosis, and epilepsy. Huntington’s disease and amyotrophic lateral sclerosis are rare diseases, unlike Alzheimer’s disease and Parkinson’s disease which have a high degree of prevalence.
This report covers the present scenario and growth prospects of the Global Travel Agencies market for the period 2015-2019. It considers both offline and online services provided for business as well as leisure customers. The report considers seven major segments of the Global Travel Agencies market based on type of service: Tour Packages, Flight Bookings, Hotel Booking Services, Cruise Bookings, Rail Bookings, Car Rental Services, and Others.
Global Travel Agencies Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the APAC region, Europe, North America and the ROW; it also covers the Global Travel Agencies market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
As per the analysts forecast the global neurodegenerative diseases market to grow at a CAGR of 4.77 percent over the period 2014-2019.
This report covers the present scenario and the growth prospects of the global neurodegenerative diseases market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of neurodegenerative diseases. The market includes data from the sales of various drugs used in the treatment of:
• Alzheimer's Disease
• Parkinson's Disease
• Multiple Sclerosis
• Huntington's Disease
• Biogen Idec
• Merck Serono
• Teva Pharmaceutical Industries
Enquire About Report:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Product Profiles
04.1.7 Exelon/Exelon Patch
Visit us at:
5933 NE Win Sivers Drive,#205, Portland, OR 97220United States